Telehealth Narcolepsy Prescribing: What PMHNPs Can Do

If you’re a psychiatrist or psychiatric nurse practitioner considering treating narcolepsy patients via telehealth, you’re probably wondering: Can I actually prescribe stimulants remotely? What are the legal limits? And is this even worth the regulatory headache?

The short answer: Yes, you can manage narcolepsy through telehealth — but the rules vary dramatically depending on whether you’re an MD or NP, and which state you’re licensed in.

Let’s cut through the confusion. Narcolepsy is a rare neurological sleep disorder affecting roughly 1 in 2,000 Americans (about 160,000 people nationwide). Most of these patients struggle to find specialists who understand their condition and can prescribe the controlled substances they need to stay awake and functional. That’s where you come in.

This isn’t your typical psychiatric prescribing. Narcolepsy treatment requires Schedule II stimulants (Adderall, Ritalin) or newer wakefulness agents like modafinil — all controlled substances with strict federal and state oversight. You’ll need to navigate DEA telehealth waivers, state scope-of-practice laws, PDMP checks, and insurance prior authorizations.

But here’s why it matters: these patients are desperate for care. Sleep specialists are scarce, especially in rural areas. Many narcolepsy patients can’t safely drive long distances due to sudden sleep attacks. Telehealth literally makes treatment accessible when it otherwise wouldn’t be.

Let’s break down exactly what psychiatrists and PMHNPs can do, state by state, and how platforms like Klarity Health remove the compliance burden so you can focus on patient care.

The Federal Landscape: DEA Telehealth Rules in 2026

First, the federal baseline. Under normal circumstances, the Ryan Haight Act requires an in-person medical evaluation before a provider can prescribe any Schedule II–V controlled substance. That means you’d need to physically see a narcolepsy patient before writing an Adderall prescription.

But that rule has been suspended since March 2020 during the COVID-19 public health emergency. As of November 2024, the DEA and HHS extended the telehealth flexibility through at least December 2025, allowing providers to prescribe controlled substances — including Schedule II stimulants — after only a video evaluation, no in-person visit required.

What happens after 2025? Nobody knows for certain. The DEA has proposed permanent telemedicine rules that would require a special ‘telemedicine registration’ and potentially mandate an in-person exam within 30 days of the first prescription. But as of early 2026, those rules haven’t been finalized. For now, you can initiate stimulant therapy entirely online.

Practical reality: If you’re treating narcolepsy patients in 2026, assume you can prescribe Schedule II stimulants via telehealth today, but have a plan B ready if federal rules tighten. That might mean partnering with local clinics for one-time in-person visits, or being prepared to transition patients to non-Schedule II alternatives like modafinil (Schedule IV).

One more federal requirement: You must be licensed in the patient’s state. No exceptions. Interstate compacts don’t cover controlled substance prescribing. So if you want to treat narcolepsy patients in Texas, California, and New York, you need three separate medical licenses.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Do: Full Prescriptive Authority

If you’re a psychiatrist (MD or DO), you have the easiest path. Psychiatrists can prescribe all narcolepsy medications — stimulants, wakefulness agents, sodium oxybate, antidepressants for cataplexy — in every state, provided you’re licensed there and follow federal DEA rules.

Your scope includes:

• Diagnosing narcolepsy (usually based on sleep study reports from a specialist)
• Initiating first-line medications like modafinil, armodafinil, amphetamine salts, or methylphenidate
• Adjusting doses and managing side effects remotely
• Prescribing adjunct medications for comorbid conditions (depression, anxiety, REM sleep behavior)
• Coordinating care with sleep specialists, primary care, or neurologists as needed

The telehealth workflow for psychiatrists is straightforward:

1. Initial evaluation: 30-45 minute video visit reviewing symptoms, obtaining sleep study documentation, ruling out mimickers (sleep apnea, depression causing fatigue), taking medical history
2. PDMP check: Required in almost all states before prescribing any controlled substance
3. E-prescribe: Using DEA-compliant electronic prescribing (EPCS) — most telehealth platforms have this built in
4. Follow-up: Monthly visits during titration (required for Schedule II refills anyway), then every 3 months once stable

State-specific caveats for psychiatrists:

Most states don’t add extra restrictions beyond federal law for physician telehealth prescribing. But there are a few outliers:

• Florida: State law prohibits prescribing Schedule II controlled substances via telehealth except for psychiatric disorders, inpatient care, or hospice. Since narcolepsy isn’t a psychiatric condition, technically you cannot tele-prescribe Adderall for narcolepsy in Florida. Workaround: Use modafinil (Schedule IV, allowed), or require one in-person visit with a Florida physician before continuing via telehealth.

• Texas: No physician-specific telehealth ban, but the Texas Medical Board requires a ‘valid practitioner-patient relationship’ which can be established via video (audio-visual, not phone-only).

In states like California, New York, Illinois, and Pennsylvania, psychiatrists face no telehealth prescribing restrictions beyond standard of care and PDMP compliance.

The business case for psychiatrists: Narcolepsy medication management is high-volume, predictable revenue. Patients need monthly visits (for Schedule II refills), billable as 99213/99214 E/M codes. Typical reimbursement: $90–$130 per visit. If you manage 20 narcolepsy patients with monthly check-ins, that’s $1,800–$2,600/month in recurring revenue per psychiatrist — and these are focused 15-minute med checks, not 60-minute therapy sessions.

With telehealth efficiency (no commute time, back-to-back scheduling), you can see more patients per hour than in-office practice. And because narcolepsy patients are chronically underserved, you’ll have steady demand.

What PMHNPs Can Do: It Depends Where You Practice

Nurse practitioners face a patchwork of state laws that either empower or handcuff their ability to treat narcolepsy. Let’s break it down by state.

Full or Near-Full Independence: California, New York, Illinois

In these states, experienced PMHNPs can manage narcolepsy patients almost identically to psychiatrists.

California (transitioning to independence):

• As of 2026, PMHNPs who’ve worked 3+ years (4,600 hours) under physician collaboration can become ‘104 NPs’ — fully independent practitioners who can diagnose and prescribe Schedule II–V without any physician oversight
• Until you hit that threshold, you need a physician collaboration via ‘standardized procedures,’ but you can still prescribe stimulants
• Bottom line: By 2026, seasoned CA PMHNPs can run independent telehealth narcolepsy practices

New York (independent after 3,600 hours):

• NY requires PMHNPs to complete 3,600 hours (roughly 2 years) under a collaborative agreement with a physician
• After that, you can practice and prescribe completely independently — no written agreement, no physician oversight
• New grads still need the collaborative agreement on file, but can prescribe stimulants under that protocol
• All NPs must check NY’s I-STOP PDMP before every controlled substance prescription

Illinois (Full Practice Authority available):

• Illinois NPs can apply for Full Practice Authority (FPA) after 4,000 clinical hours + 250 hours of pharmacology CE
• With FPA, you prescribe Schedule II–V independently (with minor exceptions: you need a physician consult relationship only for long-term opioids or benzos >120 days — not applicable to narcolepsy stimulants)
• Without FPA, you need a collaborative agreement with a physician who delegates controlled substance authority in writing

What this means: If you’re an experienced PMHNP in NY, IL, or CA, you can build a telehealth narcolepsy practice with the same clinical autonomy as a psychiatrist. You’ll handle patient acquisition, prescribing, follow-ups, and billing on your own.

Restricted Practice: Texas, Florida, Pennsylvania

These states require ongoing physician supervision and impose limits that make narcolepsy management more complicated for NPs.

Texas (physician supervision required, Schedule II banned for outpatient NPs):

• Texas mandates a Prescriptive Authority Agreement (PAA) with a supervising physician for all NP prescribing
• Here’s the kicker: Texas NPs cannot prescribe Schedule II drugs for outpatients except in hospital inpatient or hospice settings
• That means a Texas PMHNP cannot write Adderall or Ritalin prescriptions for a narcolepsy patient in a telehealth clinic
• You can prescribe modafinil (Schedule IV) independently, but for stimulant therapy, your supervising physician has to write those scripts

Florida (physician supervision + 7-day Schedule II limit):

• PMHNPs in Florida still require a collaborative agreement with a psychiatrist (the 2020 autonomous NP law excluded psychiatric specialties)
• Florida law limits NP Schedule II prescriptions to 7 days maximum unless you’re a certified ‘psychiatric nurse’ prescribing for a psychiatric disorder
• Since narcolepsy is neurological, not psychiatric, you’re stuck with weekly refills — completely impractical
• Workaround: Use modafinil, or have your collaborating psychiatrist prescribe stimulants while you manage follow-ups

Pennsylvania (collaborative agreement + 30-day Schedule II limit):

• PA requires a written collaborative agreement with a physician
• NPs can prescribe Schedule II for up to 30 days, Schedule III–IV for up to 90 days
• Beyond those limits, you need physician approval for refills
• Practically, this means monthly visits for stimulant refills (which aligns with best practice anyway)

The bottom line for restricted states: You can treat narcolepsy as a PMHNP in TX, FL, or PA — but you need a physician collaborator on your team. Platforms like Klarity Health can facilitate those relationships, pairing you with supervising psychiatrists in states where NP independence isn’t allowed yet.

State-by-State Prescribing Requirements: Quick Reference

The Economics: Is Narcolepsy Prescribing Worth It?

Let’s talk money. If you’re evaluating whether to add narcolepsy to your telehealth practice, you need to understand both the patient acquisition costs and the reimbursement reality.

Patient acquisition: Here’s what most providers don’t realize — acquiring a qualified psychiatric patient through DIY marketing (SEO, Google Ads, directory listings) typically costs $200–$500+ per patient when you account for:

• Monthly agency/consultant fees for managing campaigns
• Ad spend testing and optimization (mental health keywords cost $15–$40 per click on Google)
• Staff time to handle and qualify leads
• No-show rates from cold leads who aren’t committed
• 6–12 months of SEO investment before generating meaningful traffic
• Failed campaigns that burn budget without results

Psychology Today charges monthly directory fees and you’re competing with hundreds of other providers on the same search page. Zocdoc charges $35–$100+ per booking plus monthly subscription costs. Google Ads might cost you $200–$400+ per booked patient after accounting for click costs and conversion rates.

The Klarity Health difference: Instead of gambling $3,000–$5,000/month on marketing with uncertain ROI, you pay a standard listing fee only when a pre-qualified patient books with you. No upfront costs. No monthly subscriptions. No wasted ad spend.

You get:

• Patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate EHR or video platform fees)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

That’s guaranteed ROI versus the uncertainty of building your own marketing funnel.

Reimbursement reality: Narcolepsy medication management is typically billed as E/M codes:

• 99213 (15-min follow-up, low-moderate complexity): ~$90–$110
• 99214 (20-min follow-up, moderate complexity): ~$110–$150

Medicare and most commercial payers reimburse telehealth at parity with in-person visits in states with parity laws (CA, NY, IL, PA, FL all have some form of parity).

Medicare pays NPs at 85% of the physician fee schedule, so a PMHNP billing 99214 would get ~$95 where an MD gets ~$110. Private payers often (but not always) pay NPs equally.

One caveat: Mental health providers are historically underpaid. A 2025 analysis found private insurers pay mental health clinicians 22% less than other physicians for comparable services. This drives many psychiatrists out of network. However, narcolepsy can sometimes be billed as a neurological/medical condition (ICD-10 G47.4x codes), potentially avoiding some behavioral health reimbursement penalties.

Patient volume matters: If you manage 30 narcolepsy patients with monthly visits at $100 average reimbursement, that’s $3,000/month in recurring revenue from just that cohort. These are 15-minute focused visits, so you can stack them efficiently via telehealth.

Medication Management Workflow: What to Expect

Treating narcolepsy via telehealth follows a predictable pattern:

Month 1 (Titration):

• Initial eval: Review sleep study, confirm diagnosis, rule out other causes
• Start low-dose stimulant or modafinil
• Weekly or biweekly check-ins to assess response and side effects
• PDMP check before every prescription
• E-prescribe (30-day max for Schedule II)

Months 2-3 (Optimization):

• Dose adjustments based on Epworth Sleepiness Scale scores and patient function
• Monitor blood pressure, heart rate (ask patient to use home devices)
• Address side effects: appetite suppression, insomnia, anxiety
• Continue monthly visits (required for Schedule II refills)

Month 4+ (Maintenance):

• Stable dose; quarterly visits for medication management
• Insurance may require periodic re-authorizations (every 90-180 days)
• Coordinate with sleep specialist if symptoms worsen or cataplexy develops

Prior authorization reality: Most narcolepsy meds require PA. Modafinil, Sunosi, Wakix, and sodium oxybate all need documentation of diagnosis (usually sleep study reports) and sometimes proof of prior medication trials. This takes 30–60 minutes per patient — unpaid admin work.

The Adderall shortage complication: Since mid-2022, a national amphetamine shortage has forced many narcolepsy patients to switch medications or scramble between pharmacies. As of early 2024, the shortage continues. Telehealth providers need flexibility to quickly e-prescribe alternatives (methylphenidate, modafinil) when pharmacies can’t fill.

Compliance Checklist: Cover Your Bases

To prescribe narcolepsy meds safely and legally via telehealth:

Federal requirements:

• ✅ Active DEA registration
• ✅ Licensed in patient’s state
• ✅ Use EPCS-certified e-prescribing system
• ✅ Follow current DEA telehealth allowances (extended through 2025)
• ✅ Maintain documentation equivalent to in-person standard of care

State requirements:

• ✅ Check state PDMP before every controlled substance prescription (mandatory in most states)
• ✅ Verify no state-specific telehealth restrictions (e.g., Florida’s Schedule II ban)
• ✅ For NPs: Ensure collaborative agreement (if required) explicitly covers controlled substances
• ✅ Audio-visual format required (phone-only insufficient for controlled Rx)
• ✅ Obtain informed consent for telehealth treatment

Clinical best practices:

• ✅ Verify narcolepsy diagnosis with sleep study reports (or refer for testing)
• ✅ Screen for contraindications (cardiovascular disease, substance use history)
• ✅ Baseline vitals if starting stimulants (BP, HR)
• ✅ Monthly visits during titration, quarterly once stable
• ✅ Document every dose change, side effect, PDMP check
• ✅ Coordinate with other providers (sleep specialist, PCP)

Insurance/billing:

• ✅ Code appropriately (E/M codes, potentially add-on codes if therapy included)
• ✅ Use narcolepsy ICD-10 codes (G47.411 for type 1, G47.429 for type 2)
• ✅ Submit prior authorizations with complete documentation
• ✅ Verify telehealth parity coverage in patient’s state

Why Narcolepsy Patients Need You

Here’s the reality: narcolepsy is a rare, poorly understood disorder affecting about 160,000 Americans. Most primary care physicians don’t feel comfortable managing it. Sleep specialists are concentrated in urban academic centers — if you’re in rural Texas, upstate New York, or Central California, good luck finding one within 100 miles.

These patients experience:

• Sudden, uncontrollable sleep attacks (including while driving)
• Cataplexy (sudden muscle weakness triggered by emotion)
• Sleep paralysis and hallucinations
• Chronic fatigue that ruins careers and relationships
• Stigma — they’re often dismissed as ‘lazy’ or ‘unmotivated’

Without proper medication, many can’t work, can’t drive safely, and face serious accidents. With treatment, they can function normally.

You’re not just prescribing stimulants — you’re restoring people’s lives.

And from a workforce perspective, the national psychiatrist shortage (projected deficit of 31,000 by 2024) means patients are desperate for providers. Over 160 million Americans live in mental health professional shortage areas. If you can treat narcolepsy via telehealth across multiple states, you’re filling a critical gap.

How Klarity Health Removes the Friction

Building a solo telehealth narcolepsy practice means:

• Marketing spend with no guaranteed patients
• Compliance headaches across multiple state laws
• EHR and e-prescribing platform costs
• Insurance credentialing delays
• Prior authorization hell with no support staff

Klarity Health handles all of that:

• Pre-qualified patient flow: We match narcolepsy patients to your availability and specialty. You don’t pay unless they book.
• Multi-state licensing support: We help navigate the licensing process so you can practice in high-demand states.
• Built-in compliance: Our platform ensures PDMP integration, EPCS-certified e-prescribing, and documentation templates that meet standard of care.
• Insurance credentialing: We manage payer relationships and handle prior auth support.
• For NPs in restricted states: We can facilitate physician collaborative agreements so you can practice legally.

You focus on clinical care. We handle patient acquisition, compliance infrastructure, and administrative burden.

Pay-per-appointment model: No monthly fees. No marketing spend. You pay a standard listing fee when a qualified narcolepsy patient books with you — that’s it. Compare that to spending $3,000–$5,000/month on Google Ads and SEO with no guarantee of results.

Ready to Treat Narcolepsy Patients?

If you’re a psychiatrist or PMHNP who wants to:

• Expand your telehealth practice into an underserved specialty
• Avoid the cost and uncertainty of DIY patient acquisition
• Practice across multiple states without compliance headaches
• Actually get paid fairly for medication management

Then treating narcolepsy through Klarity Health might be your best next step.

Next steps:

1. Verify you’re licensed (or can get licensed) in states where you want to practice
2. Confirm your state allows you to prescribe narcolepsy meds via telehealth (see table above)
3. If you’re an NP in TX, FL, or PA, ensure you have or can establish a collaborative agreement
4. Join Klarity’s provider network and start seeing pre-qualified patients

No upfront costs. No marketing gamble. Just patients who need your expertise, and a platform that makes it easy to deliver care.

FAQ: Narcolepsy Prescribing for Telehealth Providers

Can psychiatrists prescribe Adderall for narcolepsy via telehealth?
Yes. As of 2026, the DEA’s COVID-era flexibilities allow psychiatrists to prescribe Schedule II stimulants like Adderall after a video evaluation, with no in-person visit required (extended through at least December 2025). You must be licensed in the patient’s state and check the state PDMP before prescribing. Exception: Florida bans telehealth Schedule II prescriptions for non-psychiatric conditions, so you’d need to use modafinil or arrange one in-person visit.

Can PMHNPs prescribe narcolepsy medications independently?
It depends on your state. In California (after 3 years experience), New York (after 3,600 hours), and Illinois (with Full Practice Authority), experienced PMHNPs can prescribe narcolepsy stimulants independently. In Texas, Florida, and Pennsylvania, you need physician supervision — and Texas specifically bans NPs from prescribing Schedule II outpatient, meaning you’d need your collaborating MD to write stimulant prescriptions.

Do I need a sleep study to prescribe narcolepsy medications?
Clinically, yes. Standard of care requires confirming narcolepsy diagnosis via polysomnography with multiple sleep latency test (MSLT) before starting treatment. If a patient doesn’t have a sleep study, you should refer them to a sleep specialist for testing. Most insurance companies require documented diagnosis for prior authorization anyway.

How often do I need to see narcolepsy patients for medication management?
Typically monthly during initial titration (required for Schedule II refills), then every 3 months once stable. Some insurers require quarterly re-evaluations for ongoing prior authorization. These are focused 15–20 minute medication management visits, billable as 99213 or 99214 E/M codes.

What’s the reimbursement for narcolepsy telehealth visits?
Medicare and commercial payers typically reimburse $90–$150 per visit depending on code (99213 vs 99214) and payer. States with telehealth parity laws pay the same rate as in-person. Medicare pays NPs at 85% of the physician fee schedule. Note: mental health providers face 22% lower reimbursement on average from private insurers, but narcolepsy can sometimes be billed as neurological rather than psychiatric.

Do I need special DEA registration for telehealth prescribing?
Currently, no. Under the extended COVID flexibilities (through December 2025), your regular DEA registration is sufficient. The DEA has proposed a ‘telemedicine registration’ requirement for permanent rules, but that hasn’t been finalized as of early 2026. You must be licensed in each state where patients reside — no exceptions.

What happens if I can’t prescribe Schedule II in my state for telehealth?
Use alternatives: modafinil or armodafinil (Schedule IV) are first-line narcolepsy treatments and allowed via telehealth in all states. For patients who need amphetamine stimulants, arrange one in-person visit with a local physician (yourself if feasible, or a partner clinic) to satisfy state requirements, then continue follow-ups via telehealth.

How do I handle the Adderall shortage?
The national amphetamine shortage (ongoing since 2022) means you need flexibility. Be prepared to switch patients to methylphenidate, modafinil, or newer agents like Sunosi. E-prescribing makes it easy to send scripts to multiple pharmacies until you find one with stock. Keep patients informed about supply issues and have backup medication plans ready.

Are narcolepsy patients hard to acquire for a telehealth practice?
If you’re marketing on your own, yes — narcolepsy is rare (1 in 2,000 people), so SEO and ads won’t generate high volume. But the patients who do have narcolepsy are desperate for specialists, especially in underserved areas. Platforms like Klarity Health solve this by aggregating patients and matching them to providers, so you don’t waste marketing dollars hunting for a tiny patient population.

Top 5 Citations

1. DEA/HHS Extension of Telehealth Controlled Substance Prescribing (Nov 2024)
   Axios, ‘COVID-era telehealth prescribing of Adderall and other controlled substances extended again’ – Confirms federal allowance to prescribe Schedule II–V via telehealth through December 2025 without in-person exam.
   www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

2. California AB 890 NP Independence Timeline (2024)
   California Board of Registered Nursing, ‘Advanced Practice Registered Nurse (AB 890)’ – Details implementation of 103/104 NP categories, confirming full independent practice available from January 2026 after 3 years experience.
   www.rn.ca.gov/practice/ab890.shtml

3. Texas NP Schedule II Prescribing Restrictions (Current)
   Texas Medical Board FAQ, ‘Who can prescribe Schedule II drugs under physician delegation?’ – Clarifies Texas law limiting NP/PA Schedule II prescribing to hospital inpatient or hospice settings only.
   www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation

4. Florida Telehealth Controlled Substance Law (SB 312) (Apr 2022)
   National Law Review, ‘New Florida Law Allows Telemedicine Prescribing of Certain Controlled Substances’ – Explains Florida’s ban on Schedule II telehealth prescribing except for psychiatric disorders, inpatient, or hospice care.
   natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances

5. Illinois Full Practice Authority for NPs (Current through 2026)
   Illinois Compiled Statutes (225 ILCS 65/65-43), ‘Advanced Practice Registered Nurse Full Practice Authority’ – Details requirements for Illinois NP independence (4,000 hours + 250 CE hours) and Schedule II prescribing authority with limited consultation requirements.
   www.ilga.gov/legislation/ILCS/details?ActID=1312

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority